Filing Details

Accession Number:
0001104659-22-041749
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-01 16:16:39
Reporting Period:
2022-03-30
Accepted Time:
2022-04-01 16:16:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Neubase Therapeutics Inc. NBSE Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1819276 Roland William Mann C/O 350 Technology Drive, Fourth Floor
Pittsburgh PA 15219
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-30 6,200 $1.92 11,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct